183 related articles for article (PubMed ID: 17425689)
21. VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway.
Villaume K; Blanc M; Gouysse G; Walter T; Couderc C; Nejjari M; Vercherat C; Cordier-Bussat M; Roche C; Scoazec JY
Neuroendocrinology; 2010; 91(3):268-78. PubMed ID: 20389030
[TBL] [Abstract][Full Text] [Related]
22. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.
Wang CA; Jedlicka P; Patrick AN; Micalizzi DS; Lemmer KC; Deitsch E; Casás-Selves M; Harrell JC; Ford HL
J Clin Invest; 2012 May; 122(5):1895-906. PubMed ID: 22466647
[TBL] [Abstract][Full Text] [Related]
23. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
Hong H; Jiang L; Lin Y; He C; Zhu G; Du Q; Wang X; She F; Chen Y
BMC Cancer; 2016 Mar; 16():240. PubMed ID: 26992854
[TBL] [Abstract][Full Text] [Related]
24. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y
BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637
[TBL] [Abstract][Full Text] [Related]
25. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Nishisho T; Yura Y; Yoneda T
Int J Oncol; 2012 Sep; 41(3):885-92. PubMed ID: 22735610
[TBL] [Abstract][Full Text] [Related]
27. Alterations of hypoxia-induced factor signaling pathway due to mammalian target of rapamycin (mTOR) suppression in ovarian clear cell adenocarcinoma: in vivo and in vitro explorations for clinical trial.
Hirasawa T; Miyazawa M; Yasuda M; Shida M; Ikeda M; Kajiwara H; Matsui N; Fujita M; Muramatsu T; Mikami M
Int J Gynecol Cancer; 2013 Sep; 23(7):1210-8. PubMed ID: 23899586
[TBL] [Abstract][Full Text] [Related]
28. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma.
Shinriki S; Jono H; Ueda M; Ota K; Ota T; Sueyoshi T; Oike Y; Ibusuki M; Hiraki A; Nakayama H; Shinohara M; Ando Y
J Pathol; 2011 Sep; 225(1):142-50. PubMed ID: 21710490
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.
Jia Y; Liu M; Huang W; Wang Z; He Y; Wu J; Ren S; Ju Y; Geng R; Li Z
Pathol Oncol Res; 2012 Apr; 18(2):315-23. PubMed ID: 21938482
[TBL] [Abstract][Full Text] [Related]
31. [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis].
Li K; Li MJ; He T; Zheng Z; Zheng XL; Qu BH; Wang Y; Duan X; Zheng YJ
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2386-90. PubMed ID: 20137690
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
[TBL] [Abstract][Full Text] [Related]
33. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
[TBL] [Abstract][Full Text] [Related]
34. Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma.
Puujalka E; Heinz M; Hoesel B; Friedl P; Schweighofer B; Wenzina J; Pirker C; Schmid JA; Loewe R; Wagner EF; Berger W; Petzelbauer P
J Invest Dermatol; 2016 May; 136(5):967-977. PubMed ID: 26829032
[TBL] [Abstract][Full Text] [Related]
35. Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.
Chen H; Guan R; Lei Y; Chen J; Ge Q; Zhang X; Dou R; Chen H; Liu H; Qi X; Zhou X; Chen C
BMC Cancer; 2015 Mar; 15():103. PubMed ID: 25884175
[TBL] [Abstract][Full Text] [Related]
36. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
37. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
38. VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model.
Shi Y; Tong M; Wu Y; Yang Z; Hoffman RM; Zhang Y; Tian Y; Qi M; Lin Y; Liu Y; Dai L; Sun Y; Wang Z
Anticancer Res; 2013 Feb; 33(2):409-17. PubMed ID: 23393331
[TBL] [Abstract][Full Text] [Related]
39. The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer.
Hisamatsu T; Mabuchi S; Sasano T; Kuroda H; Takahashi R; Matsumoto Y; Kawano M; Kozasa K; Takahashi K; Sawada K; Matsuo K; Tamada Y; Morii E; Kitadai Y; Kimura T
Clin Exp Metastasis; 2015 Dec; 32(8):789-98. PubMed ID: 26443563
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic target of rapamycin small interfering RNA and rapamycin synergistically inhibit tumour growth in a mouse xenograft model of human oesophageal carcinoma.
Sun MM; Zhang MZ; Chen Y; Li SL; Zhang W; Ya GW; Chen KS
J Int Med Res; 2012; 40(5):1636-43. PubMed ID: 23206445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]